체외식 제세동기 시장 보고서 : 제품 유형, 최종사용자, 지역별(2025-2033년)

The global external defibrillators market size reached USD 3.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.87% during 2025-2033. The rising incidence of cardiovascular diseases, expanding aging population, increasing government initiatives, and ongoing technological advancements are primarily driving the market's growth.

External defibrillators are compact, life-saving devices designed to treat individuals experiencing sudden cardiac arrest (SCA). They analyze the heart rhythm and deliver an electric shock to restore normal heart rhythm. They include a battery and pad electrodes necessary for the external defibrillators to detect and interpret an electrocardiogram. They provide voice and visual prompts to guide the healthcare personnel through the entire process from when the device is first switched on. They can also be used by non-medical personnel, including firefighters, police officers, lifeguards, flight attendants, security guards, teachers, family members of high-risk persons, and bystanders.

External Defibrillators Market Trends:

The widespread prevalence of out-of-hospital cardiac arrest (OHCA) determined by the loss of mechanical cardiac function and the absence of systemic circulation, which is a leading cause of mortality among adults, represents one of the key factors impelling the growth of the market. Moreover, there is a significant rise in the number of people with hypertension, diabetes, and obesity on account of unhealthy diets, physical inactivity, and the increasing consumption of tobacco and alcohol. These intermediate risk factors can be evaluated in primary care facilities and indicate an increased risk of a heart attack, stroke, and other complications. Besides this, external defibrillators are increasingly being kept in public areas, such as sports venues, shopping malls, airports, aircraft, businesses, convention centers, hotels, schools, and offices. Some external defibrillators are equipped with pediatric attenuator systems to reduce the delivered energy to a dose suitable for children. Apart from this, modern external defibrillators are inexpensive, easy to operate, and safe for users. This, coupled with rising technological advancements, is positively influencing the market.

Key Market Segmentation:

Breakup by Product Type:

• Manual External Defibrillator
• Automated External Defibrillator
• Semi-Automated External Defibrillator
• Fully Automated Defibrillator
• Wearable Cardioverter Defibrillator

Breakup by End User:

• Hospitals
• Pre-Hospitals
• Public Access Market
• Alternate Care Market
• Home Healthcare

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being BPL Medical Technologies Private Limited, corpuls, CU Medical Germany GmbH, Defibtech LLC, Koninklijke Philips N.V., MEDIANA Co. Ltd., Nihon Kohden Corporation, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Stryker Corporation and ZOLL Medical Corporation (Asahi Kasei Corporation).

Key Questions Answered in This Report

• 1.How big is the external defibrillators market?
• 2.What is the future outlook of external defibrillators market?
• 3.What are the key factors driving the external defibrillators market?
• 4.Which region accounts for the largest external defibrillators market share?
• 5.Which are the leading companies in the global external defibrillators market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global External Defibrillators Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Manual External Defibrillator
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Automated External Defibrillator
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Semi-Automated External Defibrillator
    • 6.2.2.2 Fully Automated Defibrillator
  • 6.2.3 Market Forecast
• 6.3 Wearable Cardioverter Defibrillator
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by End User

• 7.1 Hospitals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Pre-Hospitals
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Public Access Market
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Alternate Care Market
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Home Healthcare
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 BPL Medical Technologies Private Limited
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 corpuls
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 CU Medical Germany GmbH
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
  • 13.3.4 Defibtech LLC
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
  • 13.3.5 Koninklijke Philips N.V.
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
    • 13.3.5.4 SWOT Analysis
  • 13.3.6 MEDIANA Co. Ltd.
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
  • 13.3.7 Nihon Kohden Corporation
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
    • 13.3.7.4 SWOT Analysis
  • 13.3.8 Schiller AG
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
  • 13.3.9 Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
    • 13.3.9.4 SWOT Analysis
  • 13.3.10 Stryker Corporation
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
    • 13.3.10.3 Financials
    • 13.3.10.4 SWOT Analysis
  • 13.3.11 ZOLL Medical Corporation (Asahi Kasei Corporation)
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
    • 13.3.11.3 SWOT Analysis